Product screening
Antibodies
Proteins
APP (PTR2007) mouse mAb
Specifications
50μL;100μL
Delivery date
spot
Target
APP
Reactivity
Human,Mouse,Rat,
Application - After Update
WB,IF,ELISA
MW(Calculated)
87kD
MW(Observed)
95kD
Host Species
Mouse
Isotype
IgG2a,Kappa
Modify
Unmodified
Recommended dilution ratio
WB 1:500-2000;IF 1:100-500;ELISA 1:1000-5000
compose
PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
Store
-15°C to -25°C/1 year(Do not lower than -25°C)
Soncentration
1 mg/ml
Clonality
Monoclonal
Clone Number
PTR2007
Immunogen
Synthesized peptide derived from human APP AA range: 200-300
Specificity
This antibody detects endogenous levels of APP protein.
Gene name
APP A4 AD1
Protein name
Amyloid beta A4 protein (ABPP) (APPI) (APP) (Alzheimer disease amyloid protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99; Beta-amyloid protein 42 (Beta-APP42); Beta-amyloid protein 40 (Beta-APP40); C83; P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]
Organism-1
Human